4574 — Taiko Pharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
- ¥17bn
- ¥15bn
- ¥6bn
- 21
- 11
- 57
- 15
2019 March 31st | 2020 March 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7,225 | 9,906 | 6,098 | 3,505 | 5,484 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,619 | 4,387 | 4,056 | 1,798 | 1,985 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 12,572 | 16,584 | 13,783 | 7,556 | 9,109 |
Net Property, Plant And Equipment | 7,371 | 7,108 | 7,113 | 6,397 | 3,581 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 21,600 | 25,474 | 22,535 | 15,046 | 13,220 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,826 | 4,794 | 4,320 | 2,793 | 3,046 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 4,115 | 6,100 | 9,728 | 7,002 | 6,481 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 17,485 | 19,374 | 12,807 | 8,044 | 6,739 |
Total Liabilities & Shareholders' Equity | 21,600 | 25,474 | 22,535 | 15,046 | 13,220 |
Total Common Shares Outstanding |